3-aminobenzamide and 2-methyl-4(3h)-quinazolinone

3-aminobenzamide has been researched along with 2-methyl-4(3h)-quinazolinone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camaioni, E; Costantino, G; Macchiarulo, A; Pellicciari, R1
Kulkarni, SS; Low, WK; Shah, JR; Singh, S; Talele, TT1
Goodfellow, E; Jean-Claude, BJ; Senhaji Mouhri, Z; Williams, C1

Other Studies

3 other study(ies) available for 3-aminobenzamide and 2-methyl-4(3h)-quinazolinone

ArticleYear
Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.
    Journal of medicinal chemistry, 2001, Nov-08, Volume: 44, Issue:23

    Topics: Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; Ligands; Models, Molecular; Naphthalenes; Phenanthridines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Binding; Quantitative Structure-Activity Relationship; Quinazolines

2001
Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors.
    European journal of medicinal chemistry, 2012, Volume: 50

    Topics: Animals; BRCA1 Protein; Cells, Cultured; Embryo, Mammalian; Enzyme Inhibitors; Fibroblasts; Mice; Mice, Knockout; Models, Molecular; Molecular Structure; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Structure-Activity Relationship

2012
Design, synthesis and biological activity of novel molecules designed to target PARP and DNA.
    Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3

    Topics: Animals; Binding Sites; BRCA2 Protein; CHO Cells; Cricetinae; Cricetulus; DNA; DNA Damage; Drug Design; Enzyme Activation; Molecular Docking Simulation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Structure, Tertiary

2017